Evidence map›Paper›PMID 28643019›Full record

ArticleBreast cancer research and treatment2017

Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?

Vasileios Askoxylakis, David P Kodack, Gino B Ferraro, Rakesh K Jain

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Role of Stereotactic Biopsy in Brain Metastases.Neurosurgery clinics of North America · 2020
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Vasileios AskoxylakisEdwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
David P KodackEdwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Gino B FerraroEdwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Rakesh K JainEdwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. jain@steele.mgh.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesBrainBrain NeoplasmsHumansErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID28643019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.